A telehealth company, Hims & Hers Health, announced its intention to offer Eli Lilly's weight-loss treatment Zepbound for sale on its platform. The company's stock price rose by 8.5% during afternoon trading. (Written by Sneha S K; Editing by Arun Koyyur)
/Article